Fiche centre
Wake Forest Baptist Medical Center
Winston-Salem — United States
Essais liés3clinical trials
VilleWinston-Salemlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03472664
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| TAK-935 | Épilepsie | Phase 2 | NCT03650452 | ELEKTRA — A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies | COMPLETED |
| BEAT-AD — Brain Energy for Amyloid Transformation in Alzheimer's Disease Study | Alzheimer | Non applicable | NCT03472664 | BEAT-AD — Brain Energy for Amyloid Transformation in Alzheimer's Disease Study | COMPLETED |
| Clemizole HCl | Épilepsie | Phase 3 | NCT04462770 | ARGUS — A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome | RECRUITING |